Cargando…

Imaging Improves Diagnosis of Dementia with Lewy Bodies

Dementia with Lewy bodies (DLB) is the second most common cause of degenerative dementia after Alzheimer's disease (AD), and is clinically characterized by the progressive cognitive decline with fluctuations in cognition and alertness, recurrent visual hallucinations and Parkinsonism. Once thes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tateno, Masaru, Kobayashi, Seiju, Saito, Toshikazu
Formato:	Texto
Lenguaje:	English
Publicado:	Korean Neuropsychiatric Association 2009
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2808791/ https://www.ncbi.nlm.nih.gov/pubmed/20140120 http://dx.doi.org/10.4306/pi.2009.6.4.233

Ejemplares similares

Apolipoprotein E4 Frequencies in a Japanese Population with Alzheimer's Disease and Dementia with Lewy Bodies
por: Kobayashi, Seiju, et al.
Publicado: (2011)

Lewy body disease and dementia with Lewy bodies
por: KOSAKA, Kenji
Publicado: (2014)

Magnetic Resonance Spectroscopy in the Diagnosis of Dementia with Lewy Bodies
por: Magierski, Radoslaw, et al.
Publicado: (2014)

Clinical diagnosis of Lewy body dementia
por: Surendranathan, Ajenthan, et al.
Publicado: (2020)

Young-Onset Dementia with Lewy Bodies
por: Aiba, Yosuke, et al.
Publicado: (2018)

Catatonia as the Initial Manifestation of Dementia with Lewy Bodies
por: Saito, Yusuke, et al.
Publicado: (2021)

Revision of assessment toolkits for improving the diagnosis of Lewy body dementia: The DIAMOND Lewy study
por: Thomas, Alan J., et al.
Publicado: (2018)

Research criteria for the diagnosis of prodromal dementia with Lewy bodies
por: McKeith, Ian G., et al.
Publicado: (2020)

Neuroimaging in Lewy body dementia
por: Yousaf, Tayyabah, et al.
Publicado: (2018)

Advances in dementia with Lewy bodies
por: Armstrong, Melissa J.
Publicado: (2021)

Biomarkers for the diagnosis of Alzheimer’s disease, dementia Lewy body, frontotemporal dementia and vascular dementia
por: Maclin, Joshua Marvin Anthony, et al.
Publicado: (2019)

Neuroimaging characteristics of dementia with Lewy bodies
por: Mak, Elijah, et al.
Publicado: (2014)

Comprehensive treatment of dementia with Lewy bodies
por: Boot, Brendon P
Publicado: (2015)

Dementia with Lewy bodies: an update and outlook
por: Outeiro, Tiago Fleming, et al.
Publicado: (2019)

Dementia with Lewy bodies: Definition, diagnosis, and pathogenic relationship to Alzheimer’s disease
por: Mrak, Robert E, et al.
Publicado: (2007)

The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis
por: Donaghy, Paul C, et al.
Publicado: (2014)

Pharmacological Management of Dementia with Lewy Bodies
por: Hershey, Linda A., et al.
Publicado: (2019)

Dementia with Lewy bodies
por: McKeith, Ian
Publicado: (2004)

Improving the clinical detection of Lewy body dementia with the Lewy body composite risk score
por: Galvin, James E.
Publicado: (2015)

Development of assessment toolkits for improving the diagnosis of the Lewy body dementias: feasibility study within the DIAMOND Lewy study
por: Thomas, Alan J., et al.
Publicado: (2016)

The diagnostic performance of functional dopaminergic scintigraphic imaging in the diagnosis of dementia with Lewy bodies: an updated systematic review
por: Jreige, Mario, et al.
Publicado: (2023)

Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials
por: Goldman, Jennifer G., et al.
Publicado: (2020)

Lewy body dementia: the impact on patients and caregivers
por: Zweig, Yael R, et al.
Publicado: (2014)

Biomarkers in biological fluids for dementia with Lewy bodies
por: Schade, Sebastian, et al.
Publicado: (2014)

T Lymphocytes and Their Potential Role in Dementia with Lewy Bodies
por: Amin, Jay, et al.
Publicado: (2023)

Dementia with Lewy Bodies and Alzheimer's Disease Sometimes Coexist
por: Kobayashi, Zen
Publicado: (2022)

Cerebrospinal Fluid Biomarkers for Dementia with Lewy Bodies
por: Mukaetova-Ladinska, Elizabeta B., et al.
Publicado: (2010)

Quality of Life in Patients with Dementia with Lewy Bodies
por: Lee, Chuo-Yu, et al.
Publicado: (2018)

The role of (123)I-ioflupane SPECT dopamine transporter imaging in the diagnosis and treatment of patients with dementia with Lewy bodies
por: Antonini, Angelo
Publicado: (2007)

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
por: McKeith, Ian G., et al.
Publicado: (2017)

Microbleeds in dementia with Lewy bodies
por: Donaghy, Paul C., et al.
Publicado: (2020)

Neuroimaging in Dementia With Lewy Bodies
por: Saha, Abhishikta, et al.
Publicado: (2021)

Improving the identification of dementia with Lewy bodies in the context of an Alzheimer’s-type dementia
por: Thomas, Alan J., et al.
Publicado: (2018)

Evaluation of annexin A5 as a biomarker for Alzheimer's disease and dementia with lewy bodies
por: Sohma, Hitoshi, et al.
Publicado: (2013)

Identification of a Qualitative Signature for the Diagnosis of Dementia With Lewy Bodies
por: Zhou, Shu, et al.
Publicado: (2021)

Quantitative EEG for early differential diagnosis of dementia with Lewy bodies
por: Iannaccone, Sandro, et al.
Publicado: (2023)

Biological Studies on Alcohol-Induced Neuronal Damage
por: Tateno, Masaru, et al.
Publicado: (2008)

Lewy Body Dementias: A Coin with Two Sides?
por: Milán-Tomás, Ángela, et al.
Publicado: (2021)

Clinical and imaging correlates of amyloid deposition in dementia with Lewy bodies
por: Donaghy, Paul C., et al.
Publicado: (2018)

Diagnostic accuracy of dopaminergic imaging in prodromal dementia with Lewy bodies
por: Thomas, Alan J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kd5ncgo8t1iod8htf4grrev4on